Home LiteratureArticle Details
PMID: 18594522 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Quantitative methylation analyses of resection margins predict local recurrences and disease-specific deaths in patients with head and neck squamous cell carcinomas.

British journal of cancer ·Vol. 99 ·No. 2 ·2008-07-22 ·Pages 357-63

Tan HK, Saulnier P, Auperin A, Lacroix L, Casiraghi O, Janot F, Fouret P, Temam S

Abstract

This study sought to determine whether the presence of hypermethylated genes in the surgical margins can predict local recurrences in head and neck squamous cell carcinomas (HNSCCs). We prospectively collected tumour and surgical margin specimens from patients with HNSCCs who had undergone surgical resections. Quantitative methylation-specific PCR (QMSP) of CDKN2A, CCNA1 and DCC were performed in these specimens and correlated with clinical data. Of the 42 patients eligible for the study, 27 were hypermethylation informative for the above three genes. This latter group was associated with longer disease-free survivals (P=0.007) and longer time to disease-specific deaths (P=0.004). Multivariate analyses confirmed hypermethylation non-informative tumours as an independent prognosticating factor for disease-specific deaths (risk ratio 3.8, P=0.026). Quantitative MSP of the margins of 24 hypermethylation informative tumours revealed that 11 patients had molecularly positive margins, of which, five developed disease-specific events (DSEs, three local recurrences and two metastases), compared to none in patients with molecularly negative margins, after a median follow-up of 48 months. Log-rank analyses showed that molecularly positive margins were associated with shorter time to local recurrences and disease-specific deaths (P=0.03 and 0.01, respectively). This study demonstrated that QMSP of hypermethylated promoters in surgical margins predicted all the local recurrences in our series of HNSCC patients. We have also identified hypermethylation non-informative tumours as an independent predictor for the development of DSEs.

MeSH Terms
Adult Aged Carcinoma, Squamous Cell/genetics,pathology,surgery Cyclin A/genetics Cyclin A1 DNA Methylation Female Genes, DCC Genes, p16 Head and Neck Neoplasms/genetics,pathology,surgery Humans Male Middle Aged Neoplasm Recurrence, Local/genetics,pathology Neoplasm Staging Promoter Regions, Genetic Proportional Hazards Models
Chemicals
CCNA1 protein, human Cyclin A Cyclin A1
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Tan H K
Department of Head and Neck Surgery, Institut Gustave-Roussy, 39, Rue Camille Desmoulins, Villejuif 94805, France.
Saulnier P
Auperin A
Lacroix L
Casiraghi O
Janot F
Fouret P
Temam S
References (48)
48 references, click to expand
  1. Quantitative analysis of aberrant p16 methylation using real-time quantitative methylation-specific polymerase chain reaction.
    Cancer Res. 1999 Aug 15;59(16):3899-903 PMID: 10463578
  2. Tumor-specific methylation in saliva: a promising biomarker for early detection of head and neck cancer recurrence.
    Clin Cancer Res. 2007 Feb 15;13(4):1179-85 PMID: 17317827
  3. Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients.
    Clin Cancer Res. 2003 Apr;9(4):1370-5 PMID: 12684406
  4. Aberrant promoter hypermethylation of multiple genes in head and neck squamous cell carcinoma.
    Am J Otolaryngol. 2005 Jan-Feb;26(1):12-7 PMID: 15635575
  5. Detection of aberrant p16 methylation in the serum of colorectal cancer patients.
    Clin Cancer Res. 2002 Jan;8(1):188-91 PMID: 11801557
  6. Cancer epigenetics and methylation.
    Science. 2002 Sep 13;297(5588):1807-8; discussion 1807-8 PMID: 12229925
  7. Presence of multiple incontiguous deleted regions at the long arm of chromosome 18 in head and neck cancer.
    Clin Cancer Res. 1998 Mar;4(3):539-44 PMID: 9533520
  8. Cancer epigenetics.
    Oncogene. 2003 Sep 29;22(42):6479-83 PMID: 14528271
  9. Emerging molecular markers of cancer.
    Nat Rev Cancer. 2002 Mar;2(3):210-9 PMID: 11990857
  10. Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing.
    Br J Cancer. 2006 Feb 27;94(4):561-8 PMID: 16449996
  11. Deleted in colorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinoma.
    Cancer Res. 2006 Oct 1;66(19):9401-7 PMID: 17018594
  12. Squamous cell carcinoma of the oropharynx: why we fail.
    Am J Surg. 1976 Oct;132(4):435-8 PMID: 1015532
  13. Supraomohyoid neck dissection in the treatment of head and neck tumors. Survival results in 212 cases.
    Arch Otolaryngol Head Neck Surg. 1993 Sep;119(9):958-63 PMID: 8357596
  14. DNA methylation and cancer.
    Hum Mol Genet. 1994;3 Spec No:1487-95 PMID: 7849743
  15. Association between hypermethylated tumor and paired surgical margins in head and neck squamous cell carcinomas.
    Clin Cancer Res. 2007 Sep 1;13(17):5089-94 PMID: 17785562
  16. Detection of early micrometastases in subcutaneous fat of primary malignant melanoma patients by identification of tyrosinase-mRNA.
    Eur J Cancer. 1996 Sep;32A(10):1664-7 PMID: 8983271
  17. Molecular determination of surgical margins using fossa biopsies at radical prostatectomy.
    J Urol. 1999 May;161(5):1442-8 PMID: 10210369
  18. Intraoperative molecular margin analysis in head and neck cancer.
    Arch Otolaryngol Head Neck Surg. 2004 Jan;130(1):39-44 PMID: 14732766
  19. The prognostic relevance of p16 inactivation in head and neck cancer.
    ORL J Otorhinolaryngol Relat Spec. 2007;69(1):30-6 PMID: 17085950
  20. Tetranucleotide microsatellite instability in surgical margins for prediction of local recurrence of head and neck squamous cell carcinoma.
    Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):4022-8 PMID: 15217934
  21. Molecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: a prospective study.
    Clin Cancer Res. 2004 Jun 1;10(11):3614-20 PMID: 15173067
  22. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck.
    N Engl J Med. 1995 Feb 16;332(7):429-35 PMID: 7619114
  23. The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer.
    Gastroenterology. 2007 Jan;132(1):127-38 PMID: 17087942
  24. Cyclin A1, the alternative A-type cyclin, contributes to G1/S cell cycle progression in somatic cells.
    Oncogene. 2005 Apr 14;24(16):2739-44 PMID: 15829981
  25. Genetic progression model for head and neck cancer: implications for field cancerization.
    Cancer Res. 1996 Jun 1;56(11):2488-92 PMID: 8653682
  26. The hydra phenomenon of cancer: why tumors recur locally after microscopically complete resection.
    Cancer Res. 2005 Apr 15;65(8):2997-3002 PMID: 15833823
  27. Expanding fields of genetically altered cells in head and neck squamous carcinogenesis.
    Semin Cancer Biol. 2005 Apr;15(2):113-20 PMID: 15652456
  28. Epigenetic patterns in the progression of esophageal adenocarcinoma.
    Cancer Res. 2001 Apr 15;61(8):3410-8 PMID: 11309301
  29. The power and the promise of DNA methylation markers.
    Nat Rev Cancer. 2003 Apr;3(4):253-66 PMID: 12671664
  30. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients.
    Laryngoscope. 2002 Dec;112(12):2129-40 PMID: 12461330
  31. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients.
    Cancer Res. 1999 Jan 1;59(1):67-70 PMID: 9892187
  32. Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma.
    J Natl Cancer Inst. 2000 Nov 15;92(22):1805-11 PMID: 11078757
  33. Gene promoter hypermethylation in tumors and serum of head and neck cancer patients.
    Cancer Res. 2000 Feb 15;60(4):892-5 PMID: 10706101
  34. The incidence of p53 mutations increases with progression of head and neck cancer.
    Cancer Res. 1993 Oct 1;53(19):4477-80 PMID: 8402617
  35. Presence of tumor DNA in plasma of breast cancer patients: clinicopathological correlations.
    Cancer Res. 1999 Jul 1;59(13):3251-6 PMID: 10397273
  36. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin.
    Cancer. 1953 Sep;6(5):963-8 PMID: 13094644
  37. Role of the dependence receptor DCC in colorectal cancer pathogenesis.
    J Clin Oncol. 2004 Aug 15;22(16):3420-8 PMID: 15310786
  38. Global cancer statistics, 2002.
    CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108 PMID: 15761078
  39. Prediction of recurrence by microsatellite analysis in head and neck cancer.
    Genes Chromosomes Cancer. 2000 Nov;29(3):201-6 PMID: 10992294
  40. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer.
    N Engl J Med. 2003 Jul 17;349(3):247-57 PMID: 12867608
  41. The regulation of INK4/ARF in cancer and aging.
    Cell. 2006 Oct 20;127(2):265-75 PMID: 17055429
  42. Persistence of tumor DNA in plasma of breast cancer patients after mastectomy.
    Ann Surg Oncol. 2002 Jan-Feb;9(1):71-6 PMID: 11829433
  43. Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids.
    Cancer Res. 2000 Nov 1;60(21):5941-5 PMID: 11085508
  44. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer.
    Nat Genet. 2006 Jul;38(7):787-93 PMID: 16804544
  45. Quantitative methylation analysis of resection margins and lymph nodes in oral squamous cell carcinoma.
    Br J Oral Maxillofac Surg. 2007 Dec;45(8):617-22 PMID: 17559992
  46. p14ARF promoter hypermethylation in plasma DNA as an indicator of disease recurrence in bladder cancer patients.
    Clin Cancer Res. 2002 Apr;8(4):980-5 PMID: 11948103
  47. CpG island methylation phenotype (CIMP) in oral cancer: associated with a marked inflammatory response and less aggressive tumour biology.
    Oral Oncol. 2007 Oct;43(9):878-86 PMID: 17257884
  48. Microscopic controlled excisions for epidermoid carcinoma of the head and neck.
    Otolaryngol Head Neck Surg. 1981 Mar-Apr;89(2):244-51 PMID: 6787519
Article Info
Journal
British journal of cancer
Abbr.
Br J Cancer
ISSN
1532-1827
Published
2008-07-22
Epub
2008-00-01
Pages
357-63
Language
English
Region
England
NLM ID
0370635
PMCID
PMC2480979
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com